Benzinga - Wed, 05 May 2021 16:24:01 -0400
Benzinga - Wed, 14 Apr 2021 04:58:58 -0400
Benzinga - Tue, 13 Apr 2021 12:18:15 -0400
Benzinga - Tue, 13 Apr 2021 10:39:07 -0400
Benzinga - Wed, 07 Apr 2021 11:16:41 -0400
load more
Sector: Health Care.Industry: Biotechnology
vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.060-0.090 -0.0300
REV987.000K987.000K0
Q4 2020Est.ActualSurprise
EPS0.020
REV6.399M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VTVTvTv Therapeutics3.78%200.3M

vTv Therapeutics Company Questions & Answers

Q

How do I buy vTv Therapeutics (VTVT) stock?

A

You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are vTv Therapeutics's (VTVT) main competitors?

A

Other companies in vTv Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Voyager Therapeutics (NASDAQ:VYGR) and T2 Biosystems (NASDAQ:TTOO).

Q

What is the target price for vTv Therapeutics?

A

The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by H.C. Wainwright on 2020-02-10. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 142.91% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is vTv Therapeutics (VTVT) stock ?

A

The stock price for vTv Therapeutics (NASDAQ: VTVT) is $2.47 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next vTv Therapeutics (VTVT) dividend?

A

There are no upcoming dividends for vTv Therapeutics.

Q

When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?

A
vTv Therapeutics’s Q2 earnings are confirmed from now on August 2, 2021.
Q

When is the upcoming split for VTVT?

A

There is no upcoming split for vTv Therapeutics.